• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.45% Nasdaq Down 1.03%

    Trevena, Inc. (TRVN)

    -NasdaqGS
    5.45 Down 0.26(4.55%) Jan 30, 4:00PM EST
    Add to Portfolio
    Prev Close:5.71
    Open:5.65
    Bid:5.44 x 600
    Ask:5.48 x 200
    1y Target Est:14.75
    Beta:N/A
    Earnings Date:Mar 18 - Mar 23 (Est.)
    Day's Range:5.37 - 5.79
    52wk Range:3.80 - 9.95
    Volume:96,506
    Avg Vol (3m):170,827
    Market Cap:205.06M
    P/E (ttm):N/A
    EPS (ttm):-2.48
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for TRVN

    Comparison

    Symbol% ChgMkt Cap
    TRVNDown 4.55%205.06M
    CYTKDown 4.83%259.55M
    NVSDown 1.77%233.63B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-2.11
    Quarterly EPS Est (Dec-14) :-0.52
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Trevena, Inc., a clinical stage biopharmaceutical company, discovers, develops, and intends to commercialize therapeutics for G protein coupled receptors. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback